What is Gyre Therapeutics, Inc.'s gyre — revenue?

Gyre Therapeutics, Inc. (GYRE) reported gyre — revenue of $0 in Q1 2026.

What does gyre — revenue mean?

This represents the total revenue generated by the business segment from its primary commercial activities, excluding any sales-related taxes. It reflects the core top-line performance and market demand for the segment's products or services. Monitoring this metric helps investors assess the segment's ability to monetize its offerings and achieve commercial scale.

Gyre Therapeutics, Inc. GYRE Gyre — Revenue

Other segment segments

Gyre Pharmaceuticals

$22.52M+2.1%

All Other Segments

$0—

Similar metrics at other companies

NOVNO — Revenue

$226.75M+27.0%

KODKGrowth Products — Revenue

$1M0.0%

MPTIGR — Revenue

$0-100%

AIRProduct — Revenue (Gross)

$539.5M+29.5%

MPTIMY — Revenue

$894K-29.0%

DJT

DJTRevenue

$871.2K+6.1%

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s gyre — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s gyre — revenue?: Gyre Therapeutics, Inc. (GYRE) reported gyre — revenue of $0 in Q1 2026.
What does gyre — revenue mean?: This represents the total revenue generated by the business segment from its primary commercial activities, excluding any sales-related taxes. It reflects the core top-line performance and market demand for the segment's products or services. Monitoring this metric helps investors assess the segment's ability to monetize its offerings and achieve commercial scale.